Free Trial

Sonova Holding AG (OTCMKTS:SONVY) Given Average Recommendation of "Reduce" by Analysts

Sonova logo with Medical background

Sonova Holding AG (OTCMKTS:SONVY - Get Free Report) has received an average rating of "Reduce" from the six analysts that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation and four have issued a hold recommendation on the company.

SONVY has been the topic of several research reports. Hsbc Global Res lowered Sonova from a "strong-buy" rating to a "hold" rating in a report on Wednesday, May 21st. HSBC lowered Sonova from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st.

Read Our Latest Analysis on Sonova

Sonova Price Performance

SONVY stock traded down $0.58 on Friday, reaching $63.64. 9,157 shares of the company's stock were exchanged, compared to its average volume of 20,118. The stock has a fifty day moving average of $60.29 and a 200-day moving average of $64.37. Sonova has a twelve month low of $52.83 and a twelve month high of $77.56. The company has a current ratio of 1.21, a quick ratio of 0.82 and a debt-to-equity ratio of 0.61.

About Sonova

(Get Free Report

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

Recommended Stories

Analyst Recommendations for Sonova (OTCMKTS:SONVY)

Should You Invest $1,000 in Sonova Right Now?

Before you consider Sonova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.

While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines